Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Gains from Investment Securities (2018 - 2025)

AVITA Medical filings provide 8 years of Gains from Investment Securities readings, the most recent being -$617000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 240.23% to -$617000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$995000.0, a 305.58% decrease, with the full-year FY2025 number at $793137.0, down 77.6% from a year prior.
  • Gains from Investment Securities hit -$617000.0 in Q4 2025 for AVITA Medical, down from -$378000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.2 million in Q4 2022 to a low of -$680000.0 in Q2 2022.
  • Median Gains from Investment Securities over the past 5 years was $218920.5 (2022), compared with a mean of $500962.6.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 52900.0% in 2021 and later plummeted 384.55% in 2025.
  • AVITA Medical's Gains from Investment Securities stood at $1.8 million in 2021, then increased by 27.25% to $2.2 million in 2022, then crashed by 98.03% to $44000.0 in 2023, then skyrocketed by 900.0% to $440000.0 in 2024, then plummeted by 240.23% to -$617000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were -$617000.0 (Q4 2025), -$378000.0 (Q1 2025), and $440000.0 (Q4 2024) per Business Quant data.